CTTRF
Controladora Vuela Compania de Aviacion, S.A.B. de C.V.
No data for this timeframe.
Vol
SEC Reports6
Recent Activity
Jun 3, 2026
SEC
Volaris reported May 2026 preliminary traffic results showing a 4.9% YoY increase in RPMs on a 0.4% decrease in ASM capa
6-K — Impact 4/10
Apr 28, 2026
SEC
Volaris (CTTRF) filed its annual 20-F for FY2025, reporting a net loss of $103.9 million vs. net income of $126.4 millio
20-F — Impact 7/10
Apr 24, 2026
SEC
Controladora Vuela Compania de Aviacion's 2026 annual shareholder meeting approved its 2025 audited financial statements
6-K — Impact 6/10
Analyst Ratings
2Strong Buy
4Buy
5Hold
0Sell
0Strong Sell
Latest Reports
NEUTRAL
6-K
4/10
Volaris reported May 2026 preliminary traffic results showing a 4.9% YoY increase in RPMs on a 0.4% decrease in ASM capa
Jun 3, 2026
BEARISH
20-F
7/10
Volaris (CTTRF) filed its annual 20-F for FY2025, reporting a net loss of $103.9 million vs. net income of $126.4 millio
Apr 28, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
6 SEC filing reports analyzed. Sentiment: 0 bullish, 2 bearish, 0 mixed, 4 neutral. Avg impact: 4.3/10.
NEUTRAL
6-K
4/10
Volaris reported May 2026 preliminary traffic results showing a 4.9% YoY increase in RPMs on a 0.4%
Jun 3, 2026
BEARISH
20-F
7/10
Volaris (CTTRF) filed its annual 20-F for FY2025, reporting a net loss of $103.9 million vs. net inc
Apr 28, 2026
BEARISH
6-K
6/10
Controladora Vuela Compania de Aviacion's 2026 annual shareholder meeting approved its 2025 audited
Apr 24, 2026
NEUTRAL
6-K
2/10
Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (Volaris) amended its corporate bylaws to al
Apr 17, 2026
NEUTRAL
6-K
3/10
Controladora Vuela Compania de Aviacion, S.A.B. de C.V. (Volaris) announced a summons for its annual
Apr 8, 2026
NEUTRAL
6-K
4/10
Volaris reported March 2026 traffic results showing a 1.9% year-over-year increase in revenue passen
Apr 8, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 55% buy across 11 analysts — 2 strong buy, 4 buy, 5 hold, 0 sell, 0 strong sell. No current recommendation available.
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 2 | 4 | 5 | 0 | 0 | 55% | |
| May 1, 2026 | 2 | 4 | 5 | 0 | 0 | 55% | |
| Apr 1, 2026 | 2 | 5 | 3 | 0 | 0 | 70% | |
| Mar 1, 2026 | 2 | 6 | 2 | 0 | 0 | 80% | |
| Feb 1, 2026 | 2 | 6 | 3 | 0 | 0 | 73% | |
| Jan 1, 2026 | 2 | 6 | 3 | 0 | 0 | 73% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.